
What We're Reading: Compassionate Use Access; FDA Case Against Stem Cell Company; Problematic Nursing Homes
The government seeks make it easier for cancer patients to use experimental drugs; a federal judge says the FDA can regulate stem cell companies; US senators reveal a list of 400 troubled nursing homes.
FDA Seeks to Provide Cancer Patients With More Access to Experimental Drugs
The FDA seeks to facilitate the process for granting cancer patients “compassionate use” access to experimental drugs which have shown promising results in studies but aren’t currently available to the public, according to
Federal Judge Rules FDA Could Regulate Stem Cell Treatments
US District Court Judge Ursula Ungaro ruled in favor of the FDA yesterday in a lawsuit against US Stem Cell, a Florida-based, for-profit company whose treatments previously blinded 4 patients,
Senate Report Reveals Nursing Homes With Documented Problems
US senators Bob Casey, D-Pennsylvania, and Pat Toomey, R-Pennsylvania, released a list, provided to them by CMS, of nursing homes with a “persistent record of poor care” whose names weren’t previously disclosed to the public by the government,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.